Cas:511256-38-5 (1R)-1-(4-tert-Butylphenyl)ethanamin manufacturer & supplier

Chemical Name:(1R)-1-(4-tert-Butylphenyl)ethanamin

CAS.NO:511256-38-5

Synonyms:(R)-1-(4-tert-Butylphenyl)ethanamine;(1R)-1-[4-(2-Methyl-2-propanyl)phenyl]ethanamine;(R)-1-(4-tert-Butylphenyl)ethylamine;Benzenemethanamine, 4-(1,1-dimethylethyl)-α-methyl-, (αR)-;(1R)-1-(4-tert-Butylphenyl)ethanamin;1-chloroindane;ZY1&R DX1&1&1 &&R Form;(1R)-1-(4-tert-butylphenyl)ethanamine;(αR)-4-(1,1-Dimethylethyl)-α-methylbenzenemethanamine;(R)-4-tert-Butyl-α-methylbenzylamine

Molecular Formula:C₁₂H₁₉N

Molecular Weight:177.286

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:253.6±9.0 °C at 760 mmHg

Density:0.9±0.1 g/cm3

Index of Refraction:1.509

PSA:26.02000

Exact Mass:177.151749

LogP:3.13

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (R)-1-(4-tert-Butylphenyl)ethanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(R)-4-tert-Butyl-α-methylbenzylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(R)-1-(4-tert-Butylphenyl)ethylamine Use and application,(R)-1-(4-tert-Butylphenyl)ethanamine technical grade,usp/ep/jp grade.

Related News: The green light converts the companies’ accelerated approval to a full approval for endometrial cancer that’s not microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) and for patients whose tumors have progressed following prior treatment. 1,2-Naphthalenediol, 5-(aminomethyl)-5,6,7,8-tetrahydro- manufacturers The European Medicines Agency on Friday rejected Kyowa Kirin’s Parkinson’s disease drug Nouryant (istradefylline), which the US FDA approved in 2019 under the brand name Nourianz. (4-Bromo-phenyl)-[1-[1-(4-bromo-phenyl)-6-imino-4-(4-nitro-benzylsulfanyl)-1,6-dihydro-pyrimidin-5-yl]-meth-(E)-ylidene]-amine suppliers The European Medicines Agency on Friday rejected Kyowa Kirin’s Parkinson’s disease drug Nouryant (istradefylline), which the US FDA approved in 2019 under the brand name Nourianz. 2-{[5-(2,4-dinitro-anilino)-penta-2,4-dienylidene]-hydrazino}-4-methyl-thiazole-5-carboxylic acid ethyl ester vendor & factory Denise Bowser, commercial director at Onyx, commented, “Over the years, we have worked towards building a strong reputation in helping drug developers with complex chemistry. ,Denise Bowser, commercial director at Onyx, commented, “Over the years, we have worked towards building a strong reputation in helping drug developers with complex chemistry.